9H-xanthine is an oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.
How much products actually contain
No product states its amount yet.
Of the products containing it, 0 list it before the 1% line and 3 after it (usually 1% or less).
Products using this ingredient
3 of 3 confirmed · likeliest to carry enough first
Definition
9H-xanthine is an oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated. It has a role as a Saccharomyces cerevisiae metabolite. It is a tautomer of a 7H-xanthine.
Source: PubChem
US FDA substance register · UNII 1AVZ07U9S7 · registered name XANTHINE · single chemical substance
Cosmetic roles
Safety & regulatory references
Not classified under Korea’s toxic-substance GHS list · existing chemical substance
More data — names, identifiers, properties, test records, literature
Official labels & definitions
JCIA labelling name キサンチン: 本品は、次の化学式で表される有機化合物である。
Source: JCIA labelling names (Japan)
Names & identifiers
- CAS No.chemical registry number
- 69-89-6
- EC No.EU chemical inventory number
- 200-718-6
- DTXSIDUS EPA chemical ID
- DTXSID4035120
- DTXCIDUS EPA compound ID
- DTXCID2015120
- IUPAC
- 3,7-Dihydro-1H-purine-2,6-dione
- Molecular formula
- C5H4N4O2
- Molecular weight
- 152.113 g/mol
Measured properties
- Appearance
- Solid, [Merck Index] White odorless powder, [Alfa Aesar MSDS] · Solid
- Melting point
- > 300 °C
- Solubility
- 69 mg/L (at 16 °C) · 0.069 mg/mL at 16 °C, 9.5 mg/mL (sodium salt)
- Dissociation constant
- 7.53
- Water solubility
- 0.07 g/㎖
- Molecular weight
- 152.11
Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.
Source: PubChem · KOSHA safety data sheets (Korea)
What products actually use it for
What the 2 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Solvent1
- Softener and conditioner1
Source: US EPA CompTox dashboard
Related literature
- Inhibitory effects of xanthine oxidase inhibitor, topiroxostat, on development of neuropathy in db/db mice. · 2021
- Study on Inhibition of Xanthine Oxidase of An Extractive Complex · 2015
- INCREASED XANTHINE OXIDASE IN THE SKIN OF PREECLAMPTIC WOMEN · 2009
- [Activity detection and immunohistochemistry study on xanthine oxidase in pathological scars]. · 2008
- Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin. · 2003
Linked databases 20
- Australian Industrial Chemicals Inventory (AICIS)
- ChEBI 2
- ChEMBL
- China inventory of existing ingredients (IECIC)
- EU CosIng ingredient list 2
- JCIA labelling names (Japan)
- Korea Cosmetic Association ingredient dictionary
- Korea toxic substances GHS register (NIER)
- KOSHA safety data sheets (Korea)
- MFDS (Korea) cosmetic ingredient register 2
- NIST Chemistry WebBook
- PubChem 2
- Tlooto literature search 2 3 4 5
- UniChem cross-reference IDs
- US EPA CompTox dashboard 2
- US EPA DSSTox chemical database
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- Wikidata
- Wikipedia · Korean · English · Japanese · Chinese